MEP90808A - Dispersion formulations containing lipase inhibitors - Google Patents

Dispersion formulations containing lipase inhibitors

Info

Publication number
MEP90808A
MEP90808A MEP-908/08A MEP90808A MEP90808A ME P90808 A MEP90808 A ME P90808A ME P90808 A MEP90808 A ME P90808A ME P90808 A MEP90808 A ME P90808A
Authority
ME
Montenegro
Prior art keywords
formulations containing
lipase inhibitors
dispersion formulations
containing lipase
dispersion
Prior art date
Application number
MEP-908/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Smidt Passchier Christiaan De
Paul Hadvary
Hans Lengsfeld
Thomas Rades
Hans Steffen
Joseph Tardio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238990&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP90808(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of MEP90808A publication Critical patent/MEP90808A/xx
Publication of ME00674B publication Critical patent/ME00674B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MEP-2008-908A 1999-09-13 2000-09-11 Disperzioni preparati sa sadržajem inhibitora lipaza ME00674B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99118180 1999-09-13
PCT/EP2000/008858 WO2001019340A1 (en) 1999-09-13 2000-09-11 Dispersion formulations containing lipase inhibitors

Publications (2)

Publication Number Publication Date
MEP90808A true MEP90808A (en) 2011-12-20
ME00674B ME00674B (me) 2011-12-20

Family

ID=8238990

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-908A ME00674B (me) 1999-09-13 2000-09-11 Disperzioni preparati sa sadržajem inhibitora lipaza

Country Status (39)

Country Link
US (3) US20030181512A1 (ja)
EP (1) EP1216025B1 (ja)
JP (1) JP4217016B2 (ja)
KR (1) KR100572434B1 (ja)
CN (1) CN1197551C (ja)
AR (1) AR025587A1 (ja)
AT (1) ATE333866T1 (ja)
AU (1) AU769415B2 (ja)
BR (2) BRPI0013939B1 (ja)
CA (1) CA2383916C (ja)
CO (1) CO5180587A1 (ja)
CY (1) CY1106180T1 (ja)
CZ (1) CZ301901B6 (ja)
DE (1) DE60029602T2 (ja)
DK (1) DK1216025T3 (ja)
EG (1) EG24117A (ja)
ES (1) ES2267563T3 (ja)
HK (1) HK1049966A1 (ja)
HR (1) HRP20020205B1 (ja)
HU (1) HU228858B1 (ja)
IL (1) IL148494A0 (ja)
JO (1) JO2386B1 (ja)
MA (1) MA26818A1 (ja)
ME (1) ME00674B (ja)
MX (1) MXPA02002034A (ja)
MY (1) MY130200A (ja)
NO (1) NO331906B1 (ja)
NZ (1) NZ517545A (ja)
PE (1) PE20010595A1 (ja)
PL (1) PL199870B1 (ja)
PT (1) PT1216025E (ja)
RS (1) RS50422B (ja)
RU (1) RU2239428C2 (ja)
SI (1) SI1216025T1 (ja)
TR (1) TR200200606T2 (ja)
TW (1) TWI243060B (ja)
UY (1) UY26338A1 (ja)
WO (1) WO2001019340A1 (ja)
ZA (1) ZA200201518B (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1307264E (pt) * 2000-07-28 2005-02-28 Hoffmann La Roche Nova composicao farmaceutica
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US6730319B2 (en) * 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
FI20045076A (fi) * 2004-03-15 2005-09-16 Bioferme Oy Funktionaalinen elintarvike
PT2985026T (pt) * 2005-04-15 2022-11-03 Clarus Therapeutics Inc Sistemas de distribuição farmacêuticos para fármacos hidrófobos e composições compreendendo os mesmos
KR100910000B1 (ko) * 2005-05-13 2009-07-29 씨제이제일제당 (주) 리파아제 저해제 함유 약학 조성물
WO2006132440A1 (ja) * 2005-06-09 2006-12-14 Takeda Pharmaceutical Company Limited 固形製剤
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
KR101252635B1 (ko) * 2006-04-20 2013-04-10 (주)아모레퍼시픽 리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
TR200607613A2 (tr) * 2006-12-29 2008-07-21 NOBEL İLAÇ SAN.ve TiC.A.Ş. Lipaz inhibitörü içeren farmasötik formülasyonlar
EP1970051A1 (en) * 2007-03-14 2008-09-17 Merz Pharma GmbH & Co.KGaA Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
ATE477820T1 (de) * 2007-09-12 2010-09-15 Mader S R L Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten
EP2044930A1 (en) * 2007-10-01 2009-04-08 Nestec S.A. Composition for controlling lipase catalyzed reactions
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
KR20100075260A (ko) * 2008-12-24 2010-07-02 주식회사종근당 리파아제 저해제의 부작용 개선을 위한 신규한 약제학적 조성물
BRPI0901602B8 (pt) 2009-04-03 2021-05-25 Ems S/A formulação farmacêuticas
ITRM20120331A1 (it) 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.
WO2016166767A1 (en) * 2015-04-14 2016-10-20 Zim Laboratories Limited Pharmaceutical formulation comprising low melting, highly lipophilic drugs
CN106310287B (zh) * 2015-06-25 2019-03-19 山东省药学科学院 新利司他药用组合物及其制备方法
MY196635A (en) * 2018-06-22 2023-04-25 Sime Darby Plantation Intellectual Property Sdn Bhd Method For Reducing Formation of Free Fatty Acids in Plants
CN115105476B (zh) * 2021-03-23 2023-11-14 山东新时代药业有限公司 一种奥利司他冻干口服制剂及其制备工艺
CN114983938A (zh) * 2022-05-19 2022-09-02 广东嘉博制药有限公司 一种奥利司他口服复合乳液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
CA2128044C (en) 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
IT1282673B1 (it) 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
WO1998008490A1 (en) 1996-09-01 1998-03-05 Pharmos Corporation Solid coprecipitates for enhanced bioavailability of lipophilic substances
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
ES2239799T3 (es) 1997-02-05 2005-10-01 F. Hoffmann-La Roche Ag Uso de tetrahidrolipstatina en el tratamiento de la diabetes tipo ii.
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
EP1105122B1 (en) 1998-08-14 2005-04-27 F.Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors
PT1105123E (pt) 1998-08-14 2004-08-31 Hoffmann La Roche Composicoes farmaceuticas contendo inibidores da lipase e quitosano
US6368622B2 (en) * 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption

Also Published As

Publication number Publication date
US20040175420A1 (en) 2004-09-09
HUP0202737A2 (hu) 2003-01-28
CO5180587A1 (es) 2002-07-30
CY1106180T1 (el) 2011-06-08
NO20021204D0 (no) 2002-03-12
TR200200606T2 (tr) 2002-07-22
PL356174A1 (en) 2004-06-14
CZ20021276A3 (cs) 2003-04-16
NZ517545A (en) 2003-11-28
SI1216025T1 (sl) 2006-12-31
BRPI0013939B1 (pt) 2017-07-18
BR0013939A (pt) 2002-05-14
IL148494A0 (en) 2002-09-12
JP4217016B2 (ja) 2009-01-28
JP2003509357A (ja) 2003-03-11
HK1049966A1 (en) 2003-06-06
MA26818A1 (fr) 2004-12-20
MXPA02002034A (es) 2002-08-20
HU228858B1 (en) 2013-06-28
CA2383916A1 (en) 2001-03-22
DE60029602T2 (de) 2007-07-26
DK1216025T3 (da) 2006-10-30
ME00674B (me) 2011-12-20
KR20020063852A (ko) 2002-08-05
EG24117A (en) 2008-07-06
RS50422B (sr) 2009-12-31
CZ301901B6 (cs) 2010-07-28
EP1216025B1 (en) 2006-07-26
RU2239428C2 (ru) 2004-11-10
AR025587A1 (es) 2002-12-04
US20030181512A1 (en) 2003-09-25
AU7286300A (en) 2001-04-17
PE20010595A1 (es) 2001-05-26
NO331906B1 (no) 2012-04-30
MY130200A (en) 2007-06-29
AU769415B2 (en) 2004-01-29
PT1216025E (pt) 2006-12-29
ZA200201518B (en) 2003-07-30
EP1216025A1 (en) 2002-06-26
CN1373656A (zh) 2002-10-09
UY26338A1 (es) 2000-10-31
US8012494B2 (en) 2011-09-06
JO2386B1 (en) 2007-06-17
NO20021204L (no) 2002-03-12
CN1197551C (zh) 2005-04-20
PL199870B1 (pl) 2008-11-28
US20110275706A1 (en) 2011-11-10
HRP20020205A2 (en) 2004-04-30
WO2001019340A1 (en) 2001-03-22
TWI243060B (en) 2005-11-11
HUP0202737A3 (en) 2005-01-28
ES2267563T3 (es) 2007-03-16
DE60029602D1 (de) 2006-09-07
YU17202A (sh) 2006-01-16
HRP20020205B1 (en) 2011-06-30
CA2383916C (en) 2009-01-20
ATE333866T1 (de) 2006-08-15
KR100572434B1 (ko) 2006-04-18

Similar Documents

Publication Publication Date Title
MEP90808A (en) Dispersion formulations containing lipase inhibitors
UY26864A1 (es) Composiciones farmaceúticas de inhibidores de la proteína de transferencia de colesteril éster
TR200103216T2 (tr) Pirimidinon bileşimleri
MX9804623A (es) Precursores inactivos de farmacos inhibidores de trombina.
DE69620161T2 (de) Thrombininhibitoren
AU2002359522A1 (en) Compositions and methods of selective nucleic acid isolation
HN2001000217A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
TR199801336T2 (xx) Dezenfekte edici bile�imler.
DE69905476D1 (en) Phosphonsaürederivate als ptp-1b-inhibitoren
MXPA02010648A (es) Formulaciones liquidas.
PT871454E (pt) Inibidores fosforosos que contem protease de cisteina e de serina
BR0116166A (pt) Inibidores da serina protease
HK1029936A1 (en) Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors
NO20005813L (no) Forsterking av aktiviteten til antibakterielle oksazolidinonmidler ved anvendelse av argininderivater
DK1330258T3 (da) Kahalalid F-formulering
WO2002018954A3 (en) Inhibition of cmv infection and dissemination
BR0008382A (pt) Formulação de liberação controlada para tratamento de copd
WO2001066144A3 (en) Antineoplastic combination comprising an inhibitor of angiogenesis and an inhibitor of dna topoisomerase i enzyme activity
NO975188L (no) Anvendelse av mannanaser som slimregulerende midler
AR030593A1 (es) Sistema tensioactivo
MXPA02011558A (es) Inhibidores de mmp-2/mp-9 novedosos.
ECSP003654A (es) Formulaciones de dispersion que contienen inhibidores de lipasa
WO2001082972A3 (en) Compositions comprising carriers and transportable complexes
DE69732784D1 (de) Inhibierung von invasiver remodulierung
PL365687A1 (en) Novel trioxepan compounds